Stryker Corporation (SYK) recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC.This reflects a strategic move to streamline Stryker’s portfolio by divesting its U.S. spinal implants business, enabling the company to focus on higher-growth areas. Additionally, the planned sale of related international operations sign ...

Stryker Corporation (SYK) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks Consensus Estimate of $3.87 by 3.6%. The bottom line also improved 15.9% year over year. Our model estimate for the metric was $3.85 billion.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.GAAP EPS was $1.41, down 52.7% from the year-ago quarter’s level. The significant decline was due to recording of a goodwill and impairment charge related to SYK’s Spine business. ...

Stryker Corporation (NYSE:SYK) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neurotechnology Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Travis Steed - Bank of America David Roman - Goldman Sachs Pito Chickering - Deutsch ...

Core Viewpoint - Stryker Corporation is set to discuss its Q4 2024 earnings, highlighting key financial metrics and future outlook during the conference call [1][2]. Group 1: Company Participants - The conference call will feature key executives including Kevin Lobo (Chairman, CEO & President), Andy Pierce (Group President of MedSurg & Neurotechnology), and Glenn Boehnlein (CFO) [1]. - Other participants from various financial institutions will also be present to engage in the Q&A session [1]. Group 2: Conference Call Logistics - The call is scheduled for January 28, 2025, at 4:30 PM ET and will be recorded for replay purposes [2]. - The operator has indicated that the call may extend until no later than 6 PM EST due to the amount of content to be covered [2]. Group 3: Forward-Looking Statements - The discussions will include forward-looking statements, with potential factors affecting actual results outlined in recent SEC filings [3]. - Non-GAAP financial measures will also be discussed, with reconciliations to GAAP measures available in the press release [3].

For the quarter ended December 2024, Stryker (SYK) reported revenue of $6.44 billion, up 10.7% over the same period last year. EPS came in at $4.01, compared to $3.46 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $6.35 billion, representing a surprise of +1.34%. The company delivered an EPS surprise of +3.62%, with the consensus EPS estimate being $3.87.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expe ...

Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.62%. A quarter ago, it was expected that this medical device maker would post earnings of $2.78 per share when it actually produced earnings of $2.87, delivering a surprise of 3.24%.Over the last four quarters, the compan ...

Exhibit 99.1 STRYKER REPORTS 2024 OPERATING RESULTS AND 2025 OUTLOOK MedSurg and Neurotechnology net sales of $3.9 billion and $13.5 billion increased 10.6% in the quarter, 11.1% in constant currency, and increased 11.1% in the full year, 11.6% in constant currency. Organic net sales increased 10.1% and 11.2% in the quarter and full year including 8.5% and 9.5% from increased unit volume and 1.6% and 1.7% from higher prices. Portage, Michigan - January 28, 2025 - Stryker (NYSE:SYK) reported operating result ...

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein’s decision follows an impressive 22-year career at Stryker. Preston Wells, who currently serves as Group CFO for Stryker’s Orthopaedics Group, will assume the role of Vice President, Chief Financial Officer effective April 1, 2025. “I want to thank Glenn for his performance drive, strong business partnership, and exce ...

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billionOrganic net sales increased 10.2%Reported operating income margin of 9.0%Adjusted operating income margin(1) increased 200 bps to 29.2%Reported EPS decreased 52.7% to $1.41Adjusted EPS(1) increased 15.9% to $4.01 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Cons ...

Core Insights - Stryker has entered into a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, forming a new entity called VB Spine, LLC [1][2] - The transaction aims to enhance the focus and growth potential of the spinal implants business as an independent company [2][3] - VB Spine will have exclusive access to Stryker's Mako Spine and Copilot technologies for its spinal procedures, fostering a strategic partnership [2][3] Company Overview - Stryker is a global leader in medical technologies, impacting over 150 million patients annually with innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [5] - Viscogliosi Brothers is a family-owned investment firm focused on the neuro-musculoskeletal industry, having founded and grown 42 businesses across more than 80 countries since its establishment in 1999 [6] - Barings, LLC is a financial partner in this transaction, managing over $421 billion in assets as of December 31, 2024 [7] Transaction Details - The sale includes a binding offer to acquire Stryker's spinal implants business in France, pending employee consultations and regulatory requirements [3] - The transaction is expected to close in the first half of 2025, with both Stryker and VB Spine continuing to operate separately until then [3]